Biotech China 2014
ASCO Annual'08 Meeting
McCormick Place

Chicago, Illinois
www.asco.org/annualmeeting

Schedule of Presentations:

Friday, May 30, 2008
08:00:00 special sessions-- (Presented During a Private Function) Distinguished Service Award for Scientific Achievement Joseph R. Bertino
08:00:00 special sessions-- Distinguished Service Award for Scientific Leadership Karen H. Antman
13:00:00 geriatric oncology--Adjuvant Chemotherapy of Breast Cancer: Do We Still Need Anthracyclines? Eric P. Winer
13:00:00 professional development-- Fundamentals of Clinical Trial Design and Methodology Machael Paul Link
13:00:00 gastrointestinal (colorectal) cancer-- Advances in Anal Cancer Management (M01) Lisa A. Kachnic, Cathy Eng
13:00:00 clinical trials-- Fundamentals of Clinical Trial Design and Methodology Machael Paul Link
13:00:00 cancer prevention/epidemiology-- Single Nucleotide Polymorphisms, Clinical Trials, and Tobacco Research: Search for the Smoking Gun Margaret R. Spitz
13:00:00 practice management and information technology-- ASCO Practice Management Curriculum Douglas W. Blayney
13:00:00 developmental therapeutics-- c-MET Inhibition for Cancer Treatment Razelle Kurzrock
13:00:00 geriatric oncology-- Internal Medicine for the Oncologist Harvey Jay Cohen
13:00:00 genitourinary cancer-- Treatment of Patients with Relapsed Testicular Cancer (M25) Stephen D. Williams
13:00:00 developmental therapeutics-- The Toxicity of Targeted Therapies: Specific Effects of New Agents Joanna M. Brell
13:00:00 general oncology sessions-- The Toxicity of Targeted Therapies: Specific Effects of New Agents Joanna M. Brell
13:00:00 professional development-- A Historical Overview of the Treatment of Breast Cancer and the Evolution of Radiation Oncology Arlene A. Forastiere
13:00:00 pediatric cancer-- Prevention and Screening of Treatment-Related Cardiac Abnormalities in Survivors of Childhood Cancer Melissa Hudson
13:00:00 patient and survivor care-- The Role of Surgical Management in Stage IV Melanoma (CPO18A) Howard Kaufman
13:00:00 patient and survivor care-- The Toxicity of Targeted Therapies: Specific Effects of New Agents Joanna M. Brell
13:00:00 professional development-- Maintenance of Certification and Lifelong Learning Workshop Patrick J. Loehrer Sr., Joseph T. Ruggiero, Philip Jay Bierman
13:00:00 patient and survivor care-- Emerging Targeted Therapies in Non-Small Cell Lung Cancer Paul A. Bunn
13:00:00 patient and survivor care-- Prevention and Screening of Treatment-Related Cardiac Abnormalities in Survivors of Childhood Cancer Melissa Hudson
13:00:00 melanoma/skin cancers-- The Role of Surgical Management in Stage IV Melanoma (CPO18A) Howard Kaufman
13:00:00 meet the professor sessions-- Treatment of Patients with Relapsed Testicular Cancer(M25)
13:00:00 lung cancer-- Emerging Targeted Therapies in Non-Small Cell Lung Cancer Paul A. Bunn
13:00:00 meet the professor sessions-- Advances in Anal Cancer Management (M01) Lisa A. Kachnic, Cathy Eng
13:00:00 cancer genetics-- Single Nucleotide Polymorphisms, Clinical Trials, and Tobacco Research: Search for the Smoking Gun Margaret R. Spitz
13:00:00 clinical problems in oncology-- The Role of Surgical Management in Stage IV Melanoma (CPO18A) Howard Kaufman
13:00:00 breast cancer-- Adjuvant Chemotherapy of Breast Cancer: Do We Still Need Anthracyclines? Eric P. Winer
13:00:00 clinical trials-- Grant Writing Workshop Richard L Schilsky
14:00:00 developmental therapeutics-- Developmental Therapeutics: Immunotherapy
14:00:00 patient and survivor care-- Patient and Survivor Care
14:45:00 gastrointestinal (colorectal) cancer-- Management of Chronic Toxicities from Colorectal Cancer Systemic Therapy Paulo Marcelo Hoff
14:45:00 melanoma/skin cancers-- New Approaches to Melanoma Therapy Jeffrey Weber
14:45:00 meet the professor sessions-- Challenges in the Management of Gestational Trophoblastic Disease (M05)
14:45:00 head and neck cancer-- Management of Sarcomas and Small Round Blue Cell Tumors of the Head and Neck (CPO09A) Carol Rossier Bradford
14:45:00 tumor biology-- Tumor Immunology: Advances in Therapeutic Vaccines for Cancer Ronald Levy
14:45:00 lymphoma and plasma cell disorders-- Tumor Immunology: Advances in Therapeutic Vaccines for Cancer Ronald Levy
14:45:00 cancer genetics-- Advances in the Management of Uterine Cancer Deborah Toppmeyer
14:45:00 lung cancer-- Biomarkers of Resistance and Response in Non-Small Cell Lung Cancer Gerold Bepler
14:45:00 developmental therapeutics-- Issues in the Modulation of Angiogenesis Pathways (M10) Roy S. Herbst, Robert S. Kerbel
14:45:00 leukemia, myelodysplasia, and transplantation-- Progress and Challenges in Pediatric Acute Myeloid Leukemia Robert John Arceci
14:45:00 geriatric oncology-- Management of Chronic Toxicities from Colorectal Cancer Systemic Therapy Paulo Marcelo Hoff
14:45:00 meet the professor sessions-- Issues in the Modulation of Angiogenesis Pathways (M10) Robert S. Kerbel, Roy S. Herbst
14:45:00 clinical problems in oncology-- Management of Sarcomas and Small Round Blue Cell Tumors of the Head and Neck (CPO09A) Carol Rossier Bradford
14:45:00 breast cancer-- HER2-Targeted Therapy: Why Bother Testing? Antonio C. Wolff
14:45:00 gynecologic cancer-- Challenges in the Management of Gestational Trophoblastic Disease (M05)
14:45:00 tumor biology-- Biomarkers of Resistance and Response in Non-Small Cell Lung Cancer Gerold Bepler
14:45:00 Presentationgynecologic cancer--Advances in the Management of Uterine Cancer Deborah Toppmeyer
14:45:00 patient and survivor care-- Management of Chronic Toxicities from Colorectal Cancer Systemic Therapy Paulo Marcelo Hoff
14:45:00 pediatric cancer-- Progress and Challenges in Pediatric Acute Myeloid Leukemia Robert John Arceci
14:45:00 sarcoma/bone and soft tissue cancers-- Management of Sarcomas and Small Round Blue Cell Tumors of the Head and Neck (CPO09A) Carol Rossier Bradford
14:45:00 pediatric cancer-- Management of Sarcomas and Small Round Blue Cell Tumors of the Head and Neck (CPO09A) Carol Rossier Bradford
14:45:00 sarcoma/bone and soft tissue cancers-- Advances in the Management of Uterine Cancer Deborah Toppmeyer
15:30:00 breast cancer-- Cure the Cancer—Spare the Heart: Cardiovascular Toxicity of Modern Cancer Therapy Sandra M. Swain
15:30:00 professional development-- Career Choices: Options in Academia, Private Practice, Industry, and Government (Fellows and Junior Faculty ONLY) John E. Pippen, Jr.
16:00:00 clinical trials-- Advanced Concepts in Clinical Trial Design and Methodology Sylvan Green
16:30:00 cancer genetics-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
16:30:00 clinical problems in oncology-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07A) James C. Yao
16:30:00 meet the professor sessions-- Assessing Capacity for Decision Making and Optimizing Communication in the Older Adult with Cancer (M03) Miriam B. Rodin
16:30:00 tumor biology-- Physiologic Response Imaging in Head and Neck Cancer Clifton Ling
16:30:00 meet the professor sessions-- Treatment of Metastatic Disease in Breast Cancer (M24) Robert B. Livingston
16:30:00 pediatric cancer-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
16:30:00 patient and survivor care-- Assessing Capacity for Decision Making and Optimizing Communication in the Older Adult with Cancer (M03) Miriam B. Rodin
16:30:00 lung cancer-- Computational Aspects of Biomarker Analysis Gary M. Clark
16:30:00 head and neck cancer-- Physiologic Response Imaging in Head and Neck Cancer Clifton Ling
16:30:00 health services research-- Prostate Cancer in Black Americans: Is It a Different Disease? Otis W. Brawley
16:30:00 cancer prevention/epidemiology-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
16:30:00 gastrointestinal (colorectal) cancer-- The Multidisciplinary Management of Colorectal Cancer Liver Metastases Eric Van Cutsem
16:30:00 gastrointestinal (noncolorectal) cancer-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07A) James C. Yao
16:30:00 cancer prevention/epidemiology-- New Models for Assessment of Hereditary Cancer Risk Steve M. Lipkin
16:30:00 geriatric oncology-- Assessing Capacity for Decision Making and Optimizing Communication in the Older Adult with Cancer (M03) Miriam B. Rodin
16:30:00 breast cancer-- Treatment of Metastatic Disease in Breast Cancer (M24) Robert B. Livingston
16:30:00 cancer genetics-- New Models for Assessment of Hereditary Cancer Risk Steve M. Lipkin
16:45:00 genitourinary cancer-- Prostate Cancer in Black Americans: Is It a Different Disease? Otis W. Brawley
16:45:00 health services research-- Erythropoiesis-Stimulating Agents in Cancer Chemotherapy: Recent Developments and Clinical Implications J. Douglas Rizzo
16:45:00 clinical problems in oncology-- Management of Rare Genitourinary Tumors (CPO08A)
16:45:00 genitourinary cancer-- Management of Rare Genitourinary Tumors (CPO08A)
16:45:00 patient and survivor care-- Management of Rare Genitourinary Tumors (CPO08A)
Saturday, May 31, 2008
07:30:00 professional development-- How to Navigate the Annual Meeting (Fellows and Junior Faculty ONLY) John E. Pippen, Jr.
08:00:00 gynecologic cancer-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Michael Jon Anderson, Maurie Markman
08:00:00 breast cancer-- Preservation of Fertility in Premenopausal Women Receiving Systemic Treatment for Breast Cancer Julie Gralow
08:00:00 lymphoma and plasma cell disorders-- Lymphoma and Plasma Cell Disorders
08:00:00 lymphoma and plasma cell disorders-- Clinical Results with New Agents and Novel Drug Combinations in Multiple Myeloma: Preclinical Rationale or Empiric Success?
08:00:00 lymphoma and plasma cell disorders-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11A) Andrew David Zelenetz
08:00:00 cancer genetics-- Assessment and Prevention of Hereditary Ovarian Cancer Elizabeth M. Swisher
08:00:00 international-- Treating Breast Cancer in Developing Countries: The Eastern European Experience (M23) Alexandru E. Eniu
08:00:00 lung cancer-- Therapeutic Modalities for “Small” Stage I Lung Cancers Robert Timmerman
08:00:00 meet the professor sessions-- Treating Breast Cancer in Developing Countries: The Eastern European Experience (M23) Alexandru E. Eniu
08:00:00 meet the professor sessions-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Michael Jon Anderson, Maurie Markman
08:00:00 cancer prevention/epidemiology-- Assessment and Prevention of Hereditary Ovarian Cancer Elizabeth M. Swisher
08:00:00 developmental therapeutics-- Conjugated or “Fused” Immunoconstructs: Beyond the Naked Antibody
08:00:00 breast cancer-- Molecular Diagnostics in Breast Cancer: Prognosis and Prediction Laura van ‘ t Veer
08:00:00 developmental therapeutics-- Emerging Targets for Sarcoma Therapy
08:00:00 clinical trials-- Beyond RECIST: Meaningful and Acceptable Endpoints in Phase II Trials Robert L. Justice
08:00:00 patient and survivor care-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Michael Jon Anderson, Maurie Markman
08:00:00 gynecologic cancer-- Assessment and Prevention of Hereditary Ovarian Cancer Elizabeth M. Swisher
08:00:00 professional development-- Contract Negotiations for Your First Job in Industry, Private Practice, or Academia Sean P. Bohen
08:00:00 clinical problems in oncology-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11A) Andrew David Zelenetz
08:00:00 leukemia, myelodysplasia, and transplantation-- Leukemia, Myelodysplasia, and Transplantation
08:00:00 melanoma/skin cancers-- Melanoma: Evaluation and Management of Special Populations Julie R. Lange
08:00:00 sarcoma/bone and soft tissue cancers-- Emerging Targets for Sarcoma Therapy
08:00:00 developmental therapeutics-- Developmental Therapeutics: Molecular Therapeutics
08:00:00 genitourinary cancer-- Genitourinary Cancer
08:00:00 patient and survivor care-- Preservation of Fertility in Premenopausal Women Receiving Systemic Treatment for Breast Cancer Julie Gralow
08:00:00 patient and survivor care-- Melanoma: Evaluation and Management of Special Populations Julie R. Lange
08:00:00 gynecologic cancer-- Gynecologic Cancer
08:00:00 breast cancer-- Treating Breast Cancer in Developing Countries: The Eastern European Experience (M23) Alexandru E. Eniu
08:00:00 practice management and information technology-- Imaging for the Oncologist: What We Can See and Not See
08:00:00 pediatric cancer-- Emerging Targets for Sarcoma Therapy
08:00:00 patient and survivor care-- Striving to Live
08:00:00 clinical problems in oncology-- The Many Faces of Myelodysplasia: Head-Turning Developments (CPO16) Peter Greenberg
08:00:00 leukemia, myelodysplasia, and transplantation-- The Many Faces of Myelodysplasia: Head-Turning Developments (CPO16) Peter Greenberg
09:45:00 special sessions-- Opening Ceremony with Presidential Address, NCI Director’s Address, The ASCO Cancer Foundation Donor Appreciation Awards, and Karnofsky Memorial Award Lecture John E. Niederhuber, V. Craig Jordan, Nancy E Davidson
13:00:00 breast cancer--Therapy for HER2-expressing Breast Cancer: Efficacy and Toxicity
13:00:00 developmental therapeutics-- VEGF Pathway, Renal Cancer, and Its Treatment
13:00:00 developmental therapeutics-- Therapy for HER2-expressing Breast Cancer: Efficacy and Toxicity
13:00:00 patient and survivor care-- Therapy for HER2- expressing Breast Cancer: Efficacy and Toxicity
13:15:00 leukemia, myelodysplasia, and transplantation-- Hematopoietic Stem Cell Transplantation and Cellular Immune Therapy for Blood Cancers Frederick R Appelbaum
13:15:00 clinical problems in oncology-- The Multidisciplinary Management of Rectal Cancer (CPO17A) Bruce Minsky
13:15:00 meet the professor sessions-- Integrating Intensity- Modulated Radiation Therapy/Image-Guided Radiation Therapy and Systemic Therapy into a Combined Modality Therapeutic Strategy (M09) Stuart J. Wong, Mitchell Machtay
13:15:00 professional development-- Good to Great: Measuring Key Practice Indicators and Improving Satisfaction from Your Practice
13:15:00 pediatric cancer-- Challenges and Optimizing Outcomes in Adolescents and Young Adults with Cancer Karen H. Albritton
13:15:00 special sessions-- Controversies Around Cancer Screening
13:15:00 practice management and information technology-- Good to Great: Measuring Key Practice Indicators and Improving Satisfaction from Your Practice
13:15:00 lymphoma and plasma cell disorders-- Treatment of Aggressive B-Cell Lymphomas Richard F. Ambinder
13:15:00 lung cancer-- Non-Smoking-Related Lung Cancers
13:15:00 lymphoma and plasma cell disorders-- Hematopoietic Stem Cell Transplantation and Cellular Immune Therapy for Blood Cancers Frederick R Appelbaum
13:15:00 gastrointestinal (colorectal) cancer-- The Multidisciplinary Management of Rectal Cancer (CPO17A) Bruce Minsky
13:15:00 genitourinary cancer-- VEGF Pathway, Renal Cancer, and Its Treatment
13:15:00 gynecologic cancer-- Advances in the Management of Ovarian Cancer Sergio L. Pecorelli
13:15:00 gastrointestinal (colorectal) cancer-- Biomarkers in Colorectal Cancer Management
13:15:00 developmental therapeutics-- PI-3 Kinase/mTOR Directed Agents
13:15:00 international-- Controversies Around Cancer Screening
13:15:00 health services research-- Good to Great: Measuring Key Practice Indicators and Improving Satisfaction from Your Practice
13:15:00 head and neck cancer-- Integrating Intensity- Modulated Radiation Therapy/Image-Guided Radiation Therapy and Systemic Therapy into a Combined Modality Therapeutic Strategy (M09) Mitchell Machtay, Stuart J. Wong
13:15:00 cancer prevention/epidemiology-- Controversies Around Cancer Screening
13:15:00 general oncology sessions-- Advances in the Management of Ovarian Cancer Sergio L. Pecorelli
13:15:00 cancer prevention/epidemiology-- Diet, Energy Balance, and Cancer Risk: The Expanding Body of Data
14:00:00 gynecologic cancer-- Gynecologic Cancer
14:00:00 cancer prevention/epidemiology-- Cancer Prevention
14:00:00 melanoma/skin cancers-- Melanoma
14:00:00 head and neck cancer-- Head and Neck Cancer
14:00:00 patient and survivor care-- Patient and Survivor Care
14:00:00 lung cancer-- Lung Cancer—Local-Regional and Adjuvant Therapy
14:45:00 breast cancer-- Breast Cancer—Local-Regional and Adjuvant Therapy
15:00:00 genitourinary cancer-- Genitourinary Cancer (Testes, Kidney, and Bladder)
15:00:00 clinical trials-- Integration of Electronic Medical Records into Clinical Research: Notes from Ground 0 John F. Crowley
15:00:00 geriatric oncology-- Adjuvant Chemotherapy for Non-Small Cell Lung Cancer: Who, What, and When? (CPO01A) Heather A. Wakelee
15:00:00 sarcoma/bone and soft tissue cancers-- Complications of Cancer and Its Treatment: Identification, Evaluation, and Treatment of Neuromuscular and Musculoskeletal Sequelae and Lymphedema (CPO02A)
15:00:00 developmental therapeutics-- Developmental Therapeutics: Immunotherapy
15:00:00 general oncology sessions-- Adjuvant Chemotherapy for Non-Small Cell Lung Cancer: Who, What, and When? (CPO01A) Heather A. Wakelee
15:00:00 sarcoma/bone and soft tissue cancers-- Sarcoma
15:00:00 tumor biology-- Towards Personalized Medicine: Trials and Technologies That Will Lead to Individualized Therapy for Cancer
15:00:00 meet the professor sessions-- Management of Oligometastatic Disease in Lung Cancer (M11) Karen Kelly, Lary Robinson
15:00:00 clinical problems in oncology-- Adjuvant Chemotherapy for Non-Small Cell Lung Cancer: Who, What, and When? (CPO01A) Heather A. Wakelee
15:00:00 gastrointestinal (noncolorectal) cancer-- Multimodality Treatment of Bile Duct Tumors (M14) Michael A. Choti, Steven R. Alberts
15:00:00 clinical problems in oncology-- Complications of Cancer and Its Treatment: Identification, Evaluation, and Treatment of Neuromuscular and Musculoskeletal Sequelae and Lymphedema (CPO02A)
15:00:00 pediatric cancer-- Pediatric Cancer I
15:00:00 practice management and information technology-- Integration of Electronic Medical Records into Clinical Research: Notes from Ground 0 John F. Crowley
15:00:00 patient and survivor care-- Complications of Cancer and Its Treatment: Identification, Evaluation, and Treatment of Neuromuscular and Musculoskeletal Sequelae and Lymphedema (CPO02A)
15:00:00 lymphoma and plasma cell disorders-- Complications of Cancer and Its Treatment: Identification, Evaluation, and Treatment of Neuromuscular and Musculoskeletal Sequelae and Lymphedema (CPO02A)
15:00:00 lymphoma and plasma cell disorders-- Myeloma
15:00:00 leukemia, myelodysplasia, and transplantation-- Myeloproliferative Disorders at the Cutting Edge Ayalew Tefferi
15:00:00 lung cancer-- Management of Oligometastatic Disease in Lung Cancer (M11) Lary Robinson, Karen Kelly
15:00:00 developmental therapeutics-- Towards Personalized Medicine: Trials and Technologies That Will Lead to Individualized Therapy for Cancer
15:00:00 lung cancer-- Adjuvant Chemotherapy for Non-Small Cell Lung Cancer: Who, What, and When? (CPO01A) Heather A. Wakelee
15:00:00 meet the professor sessions-- Multimodality Treatment of Bile Duct Tumors (M14) Michael A. Choti, Steven R. Alberts
15:00:00 tumor biology-- Beyond FDG: What Will New PET Tracers Tell Us About Cancer? David A. Mankoff
15:00:00 gastrointestinal (colorectal) cancer-- Gastrointestinal (Colorectal) Cancer
15:00:00 clinical trials-- Towards Personalized Medicine: Trials and Technologies That Will Lead to Individualized Therapy for Cancer
16:30:00 patient and survivor care-- Innovative Research in Aging and Cancer
16:30:00 geriatric oncology-- Innovative Research in Aging and Cancer
16:45:00 health services research-- Measuring Quality of Care and Effecting Practice Improvement Joseph O. Jacobson
16:45:00 meet the professor sessions-- Molecular and Pharmacokinetic Aspects of Brain Metastases (M04) Patricia Steeg, Quentin R. Smith
16:45:00 clinical problems in oncology-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07B) James C. Yao
16:45:00 clinical problems in oncology-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20A) Paul Mathew
16:45:00 genitourinary cancer-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies CPO20A) Paul Mathew
16:45:00 gastrointestinal (noncolorectal) cancer-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07B) James C. Yao
16:45:00 leukemia, myelodysplasia, and transplantation-- Chronic Myeloid Leukemia: The Poster Child of Targeted Therapy Achieves Adolescence Michael W.N. Deininger
16:45:00 practice management and information technology-- Measuring Quality of Care and Effecting Practice Improvement Joseph O. Jacobson
16:45:00 general oncology sessions-- Measuring Quality of Care and Effecting Practice Improvement Joseph O. Jacobson
16:45:00 tumor biology-- Molecular and Pharmacokinetic Aspects of Brain Metastases (M04) Patricia Steeg, Quentin R. Smith
Sunday, June 1, 2008
08:00:00 international-- Erythropoiesis-Stimulating Agents Use and Overuse: How Do Oncologists Negotiate Conflicting Demands? Fadlo Raja Khuri
08:00:00 tumor biology-- Tumor Biology and Human Genetics
08:00:00 meet the professor sessions-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Rowan T. Chlebowski, Peter Ravdin
08:00:00 breast cancer-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin, Rowan T. Chlebowski
08:00:00 head and neck cancer-- Head and Neck Cancer
08:00:00 gynecologic cancer-- Gynecologic Cancer
08:00:00 pediatric cancer-- Pediatric Cancer II
08:00:00 health services research-- Health Services Research
08:00:00 geriatric oncology-- Evaluating, Treating, and Supporting Older Adults with Acute Leukemias Maria R. Baer
08:00:00 cancer prevention/epidemiology-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin, Rowan T. Chlebowski
08:00:00 special sessions-- Highlights of the Day I Clinical Trials Participation Awards
08:00:00 developmental therapeutics-- Developmental Therapeutics: Molecular Therapeutics
08:00:00 sarcoma/bone and soft tissue cancers-- Sarcoma
08:00:00 meet the professor sessions-- Prevention and Treatment of Bone Disease in Myeloma (M21) G. David Roodman
08:00:00 health services research-- Erythropoiesis-Stimulating Agents Use and Overuse: How Do Oncologists Negotiate Conflicting Demands? Fadlo Raja Khuri
08:00:00 general oncology sessions-- Upper Gastrointestinal Overview 2007-2008: Practice Implications of the Newest Data John Marshall
08:00:00 gastrointestinal (colorectal) cancer-- Gastrointestinal (Colorectal) Cancer
08:00:00 melanoma/skin cancers-- Melanoma
08:00:00 professional development-- Mid-Career Changes: Why, How, and When? William Hait
08:00:00 general oncology sessions-- Highlights of the Day I
08:00:00 clinical trials-- How to Integrate Clinical Research with Clinical Practice of Rare Tumors: Sarcomas as a Model Paolo Giovanni Casali
08:00:00 ethics-- Erythropoiesis-Stimulating Agents Use and Overuse: How Do Oncologists Negotiate Conflicting Demands? Fadlo Raja Khuri
08:00:00 sarcoma/bone and soft tissue cancers-- How to Integrate Clinical Research with Clinical Practice of Rare Tumors: Sarcomas as a Model Paolo Giovanni Casali
08:00:00 lymphoma and plasma cell disorders-- Prevention and Treatment of Bone Disease in Myeloma (M21) G. David Roodman
08:00:00 genitourinary cancer-- Genitourinary (Nonprostate) Cancer
08:00:00 lung cancer-- Lung Cancer—Local-Regional and Adjuvant Therapy
08:00:00 leukemia, myelodysplasia, and transplantation-- Evaluating, Treating, and Supporting Older Adults with Acute Leukemias Maria R. Baer
08:00:00 leukemia, myelodysplasia, and transplantation-- Advances in Acute Leukemia Therapy Wendy Stock
08:00:00 lymphoma and plasma cell disorders-- Lymphoma
08:00:00 central nervous system tumors-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
08:00:00 clinical problems in oncology-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
08:00:00 pediatric cancer-- How to Integrate Clinical Research with Clinical Practice of Rare Tumors: Sarcomas as a Model Paolo Giovanni Casali
08:00:00 breast cancer-- Breast Cancer—Metastatic
08:00:00 patient and survivor care-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
08:00:00 gastrointestinal (noncolorectal) cancer-- Upper Gastrointestinal Overview 2007-2008: Practice Implications of the Newest Data John Marshall
09:45:00 developmental therapeutics-- Molecular Imaging and Cancer: Optimizing Clinical Trials and Clinical Practice— A Joint ASCO/Society of Nuclear Medicine (SNM) Education Session Alexander J.B. (Sandy) McEwan, David A. Mankoff, Nancy E Davidson
09:45:00 developmental therapeutics-- Access to Investigational Drugs Off-Protocol: What Do We Owe Patients?
09:45:00 clinical trials-- Access to Investigational Drugs Off-Protocol: What Do We Owe Patients?
09:45:00 ethics-- Access to Investigational Drugs Off-Protocol: What Do We Owe Patients?
09:45:00 central nervous system tumors-- Chemotherapy-Induced Cognitive Impairment (M06) Tim A Ahles
09:45:00 cancer genetics-- Integration of Molecular Testing into Clinical Decision Making Steven Gutman
09:45:00 clinical trials-- Conflicts of Interest in Oncology: Understanding the Problems and Finding Solutions (CPO03) Bruce J. Roth
09:45:00 gastrointestinal (colorectal) cancer-- 2007-2008 Lower Gastrointestinal Overview: Practice Implications Charles Blanke
09:45:00 tumor biology-- Integration of Molecular Testing into Clinical Decision Making Steven Gutman
09:45:00 pediatric cancer-- Management of Sarcomas and Small Round Blue Cell Tumors of the Head and Neck (CPO09B) Carol Rossier Bradford
09:45:00 cancer genetics-- Whole Genome Association Studies in Colon, Prostate, and Breast Cancers: What Will They Mean for Cancer Diagnosis and Prevention? Stephan Gruber
09:45:00 sarcoma/bone and soft tissue cancers-- Management of Sarcomas and Small Round Blue Cell Tumors of the Head and Neck (CPO09B) Carol Rossier Bradford
09:45:00 professional development-- Conflicts of Interest in Oncology: Understanding the Problems and Finding Solutions (CPO03) Bruce J. Roth
09:45:00 clinical problems in oncology-- Conflicts of Interest in Oncology: Understanding the Problems and Finding Solutions (CPO03) Bruce J. Roth
09:45:00 special sessions-- Molecular Imaging and Cancer: Optimizing Clinical Trials and Clinical Practice— A Joint ASCO/Society of Nuclear Medicine (SNM) Education Session Alexander J.B. (Sandy) McEwan, David A. Mankoff, Nancy E Davidson
09:45:00 ethics-- Conflicts of Interest in Oncology: Understanding the Problems and Finding Solutions (CPO03) Bruce J. Roth
09:45:00 breast cancer-- Chemotherapy-Induced Cognitive Impairment (M06) Tim A Ahles
09:45:00 head and neck cancer-- Management of Sarcomas and Small Round Blue Cell Tumors of the Head and Neck (CPO09B) Carol Rossier Bradford
09:45:00 meet the professor sessions-- ASCO Internet Resources for Your Practice (M02) Edward P. Ambinder
09:45:00 meet the professor sessions-- Chemotherapy-Induced Cognitive Impairment (M06) Tim A Ahles
09:45:00 professional development-- ASCO Internet Resources for Your Practice (M02) Edward P. Ambinder
09:45:00 practice management and information technology-- ASCO Internet Resources for Your Practice (M02) Edward P. Ambinder
09:45:00 general oncology sessions-- 2007-2008 Lower Gastrointestinal Overview: Practice Implications Charles Blanke
09:45:00 geriatric oncology-- Adjuvant Therapy for Older Adults with Breast and Colon Cancers: Pharmacology and Decision Making Hyman B. Muss
09:45:00 breast cancer-- Adjuvant Therapy for Older Adults with Breast and Colon Cancers: Pharmacology and Decision Making Hyman B. Muss
09:45:00 clinical problems in oncology-- Management of Sarcomas and Small Round Blue Cell Tumors of the Head and Neck (CPO09B) Carol Rossier Bradford
09:45:00 tumor biology-- Whole Genome Association Studies in Colon, Prostate, and Breast Cancers: What Will They Mean for Cancer Diagnosis and Prevention? Stephan Gruber
09:45:00 clinical trials-- Molecular Imaging and Cancer: Optimizing Clinical Trials and Clinical Practice— A Joint ASCO/Society of Nuclear Medicine (SNM) Education Session Alexander J.B. (Sandy) McEwan, David A. Mankoff, Nancy E Davidson
09:45:00 gastrointestinal (colorectal) cancer-- Adjuvant Therapy for Older Adults with Breast and Colon Cancers: Pharmacology and Decision Making Hyman B. Muss
10:00:00 special sessions-- Training Program Directors’ Special Session
11:30:00 patient and survivor care-- Recognition and Management of Medical Errors in Oncology (CPO13) Alan M. Keller
11:30:00 clinical problems in oncology-- Recognition and Management of Medical Errors in Oncology (CPO13) Alan M. Keller
11:30:00 meet the professor sessions-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Mary K. Gospodarowicz, Lois B. Travis
11:30:00 meet the professor sessions-- Targeting Infection and Inflammation for Cancer Prevention (M22) Michael Karin
11:30:00 patient and survivor care-- Patient-Reported Outcomes in Oncology Ethan M. Basch
11:30:00 practice management and information technology-- Workforce Integration: Effectively Utilizing Nonphysician Practitioners in Oncology Practice Therese M. Mulvey
11:30:00 pediatric cancer-- Stem Cell Transplantation: Novel Donors and Indications in Pediatric Leukemias (CPO15A) James Ferrara
11:30:00 clinical problems in oncology-- Stem Cell Transplantation: Novel Donors and Indications in Pediatric Leukemias (CPO15A) James Ferrara
11:30:00 professional development-- Communicating Prognosis: How Oncologists Can Be More Effective Anthony Lee Back
11:30:00 practice management and information technology-- Recognition and Management of Medical Errors in Oncology (CPO13) Alan M. Keller
11:30:00 pediatric cancer-- Neurofibromatosis Type 1: The Development and Treatment of Neural Tumors Brigitte C. Widemann
11:30:00 patient and survivor care-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis, Mary K. Gospodarowicz
11:30:00 professional development-- Workforce Integration: Effectively Utilizing Nonphysician Practitioners in Oncology Practice Therese M. Mulvey
11:30:00 lymphoma and plasma cell disorders-- Epigenetic Approaches to Cancer Treatment: Strategies and Issues
11:30:00 lymphoma and plasma cell disorders-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Mary K. Gospodarowicz, Lois B. Travis
11:30:00 leukemia, myelodysplasia, and transplantation-- Epigenetic Approaches to Cancer Treatment: Strategies and Issues
11:30:00 developmental therapeutics-- Epigenetic Approaches to Cancer Treatment: Strategies and Issues
11:30:00 cancer prevention/epidemiology-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Mary K. Gospodarowicz
11:30:00 genitourinary cancer-- Chemotherapy for Metastatic Prostate Cancer: New Taxane Combinations and Post-Taxane Options
11:30:00 cancer prevention/epidemiology-- Targeting Infection and Inflammation for Cancer Prevention (M22) Michael Karin
11:30:00 health services research-- Patient-Reported Outcomes in Oncology Ethan M. Basch
11:30:00 ethics-- Communicating Prognosis: How Oncologists Can Be More Effective Anthony Lee Back
11:30:00 ethics-- Recognition and Management of Medical Errors in Oncology (CPO13) Alan M. Keller
11:30:00 central nervous system tumors-- The Growing Challenge of CNS Metastases: New Therapeutic Approaches Lauren E. Abrey
11:30:00 general oncology sessions-- The Growing Challenge of CNS Metastases: New Therapeutic Approaches Lauren E. Abrey
11:30:00 geriatric oncology-- Radiotherapy of Breast Cancer: Is Less More? Krystyna Kiel
11:30:00 clinical trials-- Patient-Reported Outcomes in Oncology Ethan M. Basch
11:30:00 cancer genetics-- Neurofibromatosis Type 1: The Development and Treatment of Neural Tumors Brigitte C. Widemann
11:30:00 breast cancer-- Radiotherapy of Breast Cancer: Is Less More? Krystyna Kiel
13:00:00 general oncology sessions-- Sunday Plenary Session
13:00:00 special sessions-- Sunday Plenary Session
13:00:00 special sessions-- Science of Oncology Award and Lecture Mary-Claire King
14:00:00 melanoma/skin cancers-- Melanoma
14:00:00 pediatric cancer-- Pediatric Cancer
14:00:00 developmental therapeutics-- Developmental Therapeutics: Immunotherapy
14:00:00 lung cancer-- Lung Cancer—Metastatic
14:00:00 developmental therapeutics-- Developmental Therapeutics: Cytotoxic Chemotherapy
14:00:00 health services research-- Health Services Research
14:00:00 central nervous system tumors-- Central Nervous System Tumors
14:00:00 pediatric cancer-- Pediatric Cancer
14:00:00 lung cancer-- Lung Cancer—Local-Regional and Adjuvant Therapy
14:00:00 developmental therapeutics-- Developmental Therapeutics: Molecular Therapeutics
16:30:00 developmental therapeutics-- Targeted Therapies in Gynecologic Cancers
16:30:00 breast cancer Breast Cancer-- Screening in High-Risk Women: When and How?
16:30:00 gynecologic cancer-- Targeted Therapies in Gynecologic Cancers
16:30:00 lung cancer-- Application and Limitation of Biomarker Analysis
16:30:00 cancer genetics-- Breast Cancer Screening in High-Risk Women: When and How?
16:45:00 genitourinary cancer-- Systemic Therapy for Muscle-Invasive Bladder Cancer: Who Should Receive Chemotherapy and When Cora N. Sternberg
16:45:00 tumor biology-- Predicting and Targeting Drug Resistance to Tyrosine Kinase Inhibitors Jeffrey Adam Engelman
16:45:00 gastrointestinal (noncolorectal) cancer-- Intraperitoneal Treatment for Gastrointestinal Cancer: Role of Debulking and Chemotherapy Cathy Eng
16:45:00 leukemia, myelodysplasia, and transplantation-- Advances in Chronic Lymphocytic Leukemia from Biology to Bedside Thomas J. Kipps
16:45:00 gastrointestinal (colorectal) cancer-- Intraperitoneal Treatment for Gastrointestinal Cancer: Role of Debulking and Chemotherapy Cathy Eng
16:45:00 central nervous system tumors-- Central Nervous System Lymphoma (M07) Gregory C DeAngelis
16:45:00 lymphoma and plasma cell disorders-- The Role of Maintenance Therapy in Follicular Lymphoma: Pros and Cons Peter McLaughlin
16:45:00 lymphoma and plasma cell disorders-- Central Nervous System Lymphoma (M07)
16:45:00 patient and survivor care-- New Models for Survivorship Care Programs (M15) Lawrence N. Shulman, Patricia A Ganz
16:45:00 sarcoma/bone and soft tissue cancers-- Predicting and Targeting Drug Resistance to Tyrosine Kinase Inhibitors Jeffrey Adam Engelman
16:45:00 patient and survivor care-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists Teresa Gilewski
16:45:00 gastrointestinal (colorectal) cancer-- The Multidisciplinary Management of Rectal Cancer (CPO17B) Bruce Minsky
16:45:00 cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
16:45:00 clinical problems in oncology-- The Multidisciplinary Management of Rectal Cancer (CPO17B) Bruce Minsky
16:45:00 meet the professor sessions-- Central Nervous System Lymphoma (M07)
16:45:00 meet the professor sessions-- New Models for Survivorship Care Programs (M15) Lawrence N. Shulman, Patricia A Ganz
16:45:00 professional development-- Navigating the Process of Maintenance of Certification John E. Pippen, Jr.
16:45:00 professional development-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists Teresa Gilewski
16:45:00 breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
16:45:00 clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
16:45:00 cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
16:45:00 general oncology sessions-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists Teresa Gilewski
Monday, June 2, 2008
08:00:00 pediatric cancer-- Rhabdomyosarcoma in Children and Adolescents: From Biology to New Therapies William H. Meyer
08:00:00 gastrointestinal (noncolorectal) cancer-- Gastrointestinal (Noncolorectal) Cancer
08:00:00 clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
08:00:00 leukemia, myelodysplasia, and transplantation-- Leukemia, Myelodysplasia, and Transplantation
08:00:00 gastrointestinal (colorectal) cancer-- Gastrointestinal (Colorectal) Cancer
08:00:00 central nervous system tumors-- Central Nervous System Tumors
08:00:00 cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
08:00:00 health services research-- Cancer and Thrombosis I: The Risk of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
08:00:00 geriatric oncology-- Opportunities for Clinicians and Researchers Interested in Geriatric Oncology (M16) Arash Naeim, Arti Hurria
08:00:00 meet the professor sessions-- Optimal Management of Stage III Non-Small Cell Lung Cancer (M17) Minesh P. Mehta, Everett E Vokes
08:00:00 cancer genetics-- Rhabdomyosarcoma in Children and Adolescents: From Biology to New Therapies William H. Meyer
08:00:00 meet the professor sessions-- Opportunities for Clinicians and Researchers Interested in Geriatric Oncology (M16) Arash Naeim, Arti Hurria
08:00:00 patient and survivor care-- Cancer and Thrombosis I: The Risk of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
08:00:00 gastrointestinal (noncolorectal) cancer-- Developing a Patient- Tailored Strategy to Stratify and Treat Patients with Pancreatic Cancer
08:00:00 cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
08:00:00 developmental therapeutics-- Developmental Therapeutics: Cytotoxic Chemotherapy
08:00:00 genitourinary cancer-- Genitourinary Cancer (Prostate and Testes)
08:00:00 lung cancer-- New Developments in Management of Malignant Mesothelioma Hedy L. Kindler
08:00:00 lung cancer-- Lung Cancer—Metastatic
08:00:00 international-- Choice of Comparator in Pivotal Phase III Clinical Trials: Clinical Versus Regulatory Standard of Care Steven D. Averbuch
08:00:00 clinical trials-- Choice of Comparator in Pivotal Phase III Clinical Trials: Clinical Versus Regulatory Standard of Care Steven D. Averbuch
08:00:00 breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
08:00:00 clinical problems in oncology-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11B) Andrew David Zelenetz
08:00:00 cancer genetics-- Rhabdomyosarcoma in Children and Adolescents:From Biology to New Therapies William H. Meyer
08:00:00 breast cancer-- Breast Cancer—Local-Regional and Adjuvant Therapy
08:00:00 lung cancer-- Optimal Management of Stage III Non-Small Cell Lung Cancer (M17) Minesh P. Mehta, Everett E Vokes
08:00:00 tumor biology-- Tumor Biology and Human Genetics
08:00:00 cancer prevention/epidemiology-- Cancer Prevention
08:00:00 lymphoma and plasma cell disorders-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11B) Andrew David Zelenetz
08:00:00 breast cancer-- What Can We Learn About Breast Cancer from Neoadjuvant Systemic Therapy? Matthew James Ellis
08:00:00 special sessions-- Highlights of the Day II
08:00:00 general oncology sessions-- Highlights of the Day II
08:00:00 sarcoma/bone and soft tissue cancers-- Rhabdomyosarcoma in Children and Adolescents: From Biology to New Therapies William H. Meyer
08:00:00 professional development-- Teaching the Teacher: Keys to Speaker Success Larry Norton
08:00:00 professional development-- Opportunities for Clinicians and Researchers Interested in Geriatric Oncology (M16) Arash Naeim, Arti Hurria
09:45:00 clinical trials-- Decision Making in Cancer Drug Development: Role of Biomarkers in First-in Human Studies Patricia LoRusso
09:45:00 clinical problems in oncology-- Treating Localized Pancreatic Cancer: Are We Offering Patients the Best We Have? (CPO19A) Philip Agop Philip
09:45:00 developmental therapeutics-- Decision Making in Cancer Drug Development: Role of Biomarkers in First–in Human Studies Patricia LoRusso
09:45:00 gastrointestinal (colorectal) cancer-- Liver-Directed Therapy: Beyond Colon Metastasis (CPO06B) Michael A. Choti
09:45:00 international-- ASCO/European CanCer Organisation Joint Symposium 2008: How Can We Overcome Difficulties of Clinical Vaccine Development in Oncology? Alexander M. Eggermont, Nancy E Davidson
09:45:00 gastrointestinal (noncolorectal) cancer-- Liver-Directed Therapy: Beyond Colon Metastasis (CPO06B) Michael A. Choti
09:45:00 gastrointestinal (noncolorectal) cancer-- Treating Localized Pancreatic Cancer: Are We Offering Patients the Best We Have? (CPO19A) Philip Agop Philip
09:45:00 tumor biology-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
09:45:00 breast cancer-- Factors Mediating Endocrine Therapy Response and Resistance
09:45:00 special sessions-- ASCO/European CanCer Organisation Joint Symposium 2008: How Can We Overcome Difficulties of Clinical Vaccine Development in Oncology? Alexander M. Eggermont, Nancy E Davidson
09:45:00 sarcoma/bone and soft tissue cancers-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
09:45:00 clinical problems in oncology-- Liver-Directed Therapy: Beyond Colon Metastasis (CPO06B) Michael A. Choti
09:45:00 pediatric cancer-- The Challenge of Pediatric High-Grade Gliomas David M. Panchision
09:45:00 professional development-- Using the Internet to Keep Current: From Podcasts to Virtual Meetings to RSS L. Michael Glode
09:45:00 practice management and information technology-- Using the Internet to Keep Current: From Podcasts to Virtual Meetings to RSS L. Michael Glode
09:45:00 genitourinary cancer-- Cancer Care in Minority Populations Derek Raghavan
09:45:00 health services research-- Cancer Care in Minority Populations Derek Raghavan
09:45:00 meet the professor sessions-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
09:45:00 central nervous system tumors-- The Challenge of Pediatric High-Grade Gliomas David M. Panchision
11:30:00 genitourinary cancer New Targeted Strategies for Patients with Prostate Cancer
11:30:00 patient and survivor care-- Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
11:30:00 clinical problems in oncology-- Management of Rare Genitourinary Tumors (CPO08B)
11:30:00 developmental therapeutics-- Novel Antiangiogenic Mechanisms
11:30:00 breast cancer-- Endocrine Therapy of Breast Cancer in the Adjuvant Setting Kathy I. Pritchard
11:30:00 professional development-- Financial Planning and Managing Debt at the Beginning of Your Career
11:30:00 pediatric cancer-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
11:30:00 patient and survivor care-- Management of Rare Genitourinary Tumors (CPO08B)
11:30:00 patient and survivor care-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
11:30:00 patient and survivor care-- Cancer and Thrombosis II: The Prevention of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
11:30:00 geriatric oncology-- New Targeted Strategies for Patients with Prostate Cancer
11:30:00 special sessions-- American Cancer Society Award and Lecture Patricia A Ganz
11:30:00 health services research-- Cancer and Thrombosis II: The Prevention of Venous Thromboembolism (VTE) in Patients with Cancer Gary H. Lyman
11:30:00 cancer genetics-- Applied Pharmacogenomics in Predicting Drug Toxicity and Symptom Severity in Patients with Cancer
11:30:00 tumor biology-- The Role of Stem Cells in Gliomas
11:30:00 central nervous system tumors-- The Role of Stem Cells in Gliomas
11:30:00 cancer prevention/epidemiology-- Applied Pharmacogenomics in Predicting Drug Toxicity and Symptom Severity in Patients with Cancer
11:30:00 developmental therapeutics-- Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
11:30:00 head and neck cancer-- Radiotherapy, Surgery, Chemoradiotherapy, or Sequential Therapy for Head and Neck Cancer: Treatment Decision Making in a Heterogeneous and Complicated Patient Population (CPO12A) Jacques Bernier
11:30:00 leukemia, myelodysplasia, and transplantation-- Targeted Therapies: Substance or Slogan
11:30:00 clinical problems in oncology-- Radiotherapy, Surgery, Chemoradiotherapy, or Sequential Therapy for Head and Neck Cancer: Treatment Decision Making in a Heterogeneous and Complicated Patient Population (CPO12A) Jacques Bernier
11:30:00 developmental therapeutics The Role of Stem Cells in Gliomas
11:30:00 general oncology sessions-- Endocrine Therapy of Breast Cancer in the Adjuvant Setting Kathy I. Pritchard
11:30:00 gastrointestinal (noncolorectal) cancer Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
11:30:00 patient and survivor care-- Applied Pharmacogenomics in Predicting Drug Toxicity and Symptom Severity in Patients with Cancer
11:30:00 sarcoma/bone and soft tissue cancers-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
11:30:00 genitourinary cancer Management of Rare Genitourinary Tumors (CPO08B)
13:15:00 genitourinary cancer-- Rationale Strategies for the Choice of Therapy for Patients with Metastatic Kidney Cancer Walter Michael Stadler
13:15:00 clinical problems in oncology-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20B) Paul Mathew
13:15:00 clinical problems in oncology-- Stem Cell Transplantation: Novel Donors and Indications in Pediatric Leukemias (CPO15B) James Ferrara
13:15:00 tumor biology-- Targeting Novel Pathways in Melanoma Thomas F Gajewski
13:15:00 tumor biology-- Cohort Identification for Cancer Prevention and Early Detection: Risk in the Balance Michael J. Kelley
13:15:00 meet the professor sessions-- Optimizing Your Clinical Trials Program (M18) Deborah Bruner, Kim Margolin
13:15:00 tumor biology-- Monitoring Therapeutic Response: Imaging, Circulating Cells, and Other Biomarkers
13:15:00 special sessions-- Pediatric Oncology Award and Lecture Larry E. Kun
13:15:00 tumor biology-- Rationale Strategies for the Choice of Therapy for Patients with Metastatic Kidney Cancer Walter Michael Stadler
13:15:00 practice management and information technology-- Optimizing Your Clinical Trials Program (M18) Deborah Bruner, Kim Margolin
13:15:00 pediatric cancer-- Stem Cell Transplantation: Novel Donors and Indications in Pediatric Leukemias (CPO15B) James Ferrara
13:15:00 patient and survivor care-- Optimizing Your Clinical Trials Program (M18) Deborah Bruner, Kim Margolin
13:15:00 special sessions-- An Update from the President’s Cancer Panel LaSalle D. Leffall Jr.
13:15:00 pediatric cancer-- Pediatric Oncology Award and Lecture Larry E. Kun
13:15:00 patient and survivor care-- An Update on Current Approaches to the Treatment of Fatigue and Insomnia in Patients with Cancer
13:15:00 melanoma/skin cancers-- Targeting Novel Pathways in Melanoma Thomas F Gajewski
13:15:00 lymphoma and plasma cell disorders-- Advances in Immunotherapy for Lymphoma and Multiple Myeloma: Complementing Conventional and Novel Chemotherapy
13:15:00 lung cancer-- Current Status and Future Prospects of Lung Cancer Imaging
13:15:00 clinical trials-- Optimizing Your Clinical Trials Program (M18) Deborah Bruner, Kim Margolin
13:15:00 clinical trials-- Early Data: Presenting and Publishing Preliminary Results Donna S. Neuberg
13:15:00 gastrointestinal (noncolorectal) cancer-- Resectable Esophageal, Gastroesophageal Junction, and Gastric Cancers: Should We Treat Them All the Same? Mark Krasna
13:15:00 developmental therapeutics-- Targeting Novel Pathways in Melanoma Thomas F Gajewski
13:15:00 cancer prevention/epidemiology-- Cohort Identification for Cancer Prevention and Early Detection: Risk in the Balance Michael J. Kelley
13:15:00 head and neck cancer-- Hypothesis, Evidence, and Experience in Choosing Sequential Chemoradiation for Advanced Head and Neck Cancer
13:15:00 gynecologic cancer-- An Update on Current Approaches to the Treatment of Fatigue and Insomnia in Patients with Cancer
13:15:00 clinical trials-- Monitoring Therapeutic Response: Imaging, Circulating Cells, and Other Biomarkers
13:15:00 genitourinary cancer What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20B) Paul Mathew
13:15:00 developmental therapeutics Novel Antimitotic Strategies
13:15:00 geriatric oncology-- An Update on Current Approaches to the Treatment of Fatigue and Insomnia in Patients with Cancer
13:15:00 breast cancer Monitoring-- Therapeutic Response: Imaging, Circulating Cells, and Other Biomarkers
13:15:00 general oncology sessions-- Rationale Strategies for the Choice of Therapy for Patients with Metastatic Kidney Cancer Walter Michael Stadler
14:00:00 developmental therapeutics-- Developmental Therapeutics: Cytotoxic Chemotherapy
14:00:00 leukemia, myelodysplasia, and transplantation-- Leukemia, Myelodysplasia, and Transplantation
14:00:00 breast cancer-- Breast Cancer—Metastatic
14:00:00 breast cancer-- Breast Cancer—Local-Regional and Adjuvant Therapy
14:00:00 central nervous system tumors-- Central Nervous System Tumors
14:00:00 genitourinary cancer-- Genitourinary (Prostate) Cancer
15:00:00 leukemia, myelodysplasia, and transplantation-- ASCO/American Society of Hematology Symposium. Reducing and Enhancing Hematopoietic Cell Growth: New Developments in the Pathogenesis and Treatment of Acute Leukemia and the Therapeutic Uses of Hematopoietic Growth Factors Kenneth Kaushansky, Nancy E Davidson
15:00:00 gastrointestinal (noncolorectal) cancer-- Gastrointestinal (Noncolorectal) Cancer
15:00:00 lung cancer-- Adjuvant Chemotherapy for Non-Small Cell Lung Cancer: Who, What, and When? (CPO01B) Heather A. Wakelee
15:00:00 lymphoma and plasma cell disorders-- ASCO/American Society of Hematology Symposium. Reducing and Enhancing Hematopoietic Cell Growth: New Developments in the Pathogenesis and Treatment of Acute Leukemia and the Therapeutic Uses of Hematopoietic Growth Factors Kenneth Kaushansky, Nancy E Davidson
15:00:00 head and neck cancer-- Head and Neck Cancer
15:00:00 developmental therapeutics-- Novel Biomarkers for Melanoma Outcome
15:00:00 melanoma/skin cancers-- Novel Biomarkers for Melanoma Outcome
15:00:00 patient and survivor care-- Patient and Survivor Care
15:00:00 tumor biology-- Hypoxia as a Therapeutic Target Amato J Giaccia
15:00:00 professional development-- How to Write an Outstanding Manuscript Arlene A. Forastiere
15:00:00 geriatric oncology-- Adjuvant Chemotherapy for Non-Small Cell Lung Cancer: Who, What, and When? (CPO01B) Heather A. Wakelee
15:00:00 general oncology sessions-- Adjuvant Chemotherapy for Non-Small Cell Lung Cancer: Who, What, and When? (CPO01B) Heather A. Wakelee
15:00:00 clinical problems in oncology-- Adjuvant Chemotherapy for Non-Small Cell Lung Cancer: Who, What, and When? (CPO01B) Heather A. Wakelee
15:00:00 breast cancer-- Controversies in Breast Cancer Staging: Sentinel Lymph Node Biopsy and Imaging Eleftherios P. Mamounas
15:00:00 cancer prevention/epidemiology-- Clinical Testing of Agents for Cancer Prevention: The Price of Progress
15:00:00 clinical trials-- Endpoints for Immunotherapy Studies: Design and Regulatory Implications Axel Hoos
15:00:00 gastrointestinal (noncolorectal) cancer-- Gastrointestinal Stromal Tumor (GIST) Comes of Age: Current Management Using Molecular Pathology, Surgery, and Targeted Therapy George Daniel Demetri
15:00:00 health services research-- Health Services Research
15:00:00 special sessions-- ASCO/American Society of Hematology Symposium. Reducing and Enhancing Hematopoietic Cell Growth: New Developments in the Pathogenesis and Treatment of Acute Leukemia and the Therapeutic Uses of Hematopoietic Growth Factors Kenneth Kaushansky, Nancy E Davidson
15:00:00 tumor biology-- Endpoints for Immunotherapy Studies: Design and Regulatory Implications Axel Hoos
15:00:00 special sessions-- B. J. Kennedy Award and Lecture for Scientific Excellence in Geriatric Oncology Hyman B. Muss
15:00:00 lung cancer-- Lung Cancer—Metastatic
15:00:00 sarcoma/bone and soft tissue cancers-- Gastrointestinal Stromal Tumor (GIST) Comes of Age: Current Management Using Molecular Pathology, Surgery, and Targeted Therapy
15:00:00 geriatric oncology-- B. J. Kennedy Award and Lecture for Scientific Excellence in Geriatric Oncology Hyman B. Muss
16:30:00 developmental therapeutics-- Novel Targeted Therapy for Breast Cancer: What Targets? What Agents?
16:30:00 breast cancer-- Novel Targeted Therapy for Breast Cancer: What Targets? What Agents?
16:30:00 tumor biology-- Novel Targeted Therapy for Breast Cancer: What Targets? What Agents?
16:45:00 pediatric cancer-- Melanoma in Children, Adolescents, and Young Adults David E Fisher
16:45:00 professional development-- Lifelong Strategies for Stress and Time Management to Avoid Burnout Laurie Jean Lyckholm
16:45:00 gynecologic cancer-- Benefit of Multimodality Management of Advanced Sarcoma: Why the Medical Oncologist Should Not Work Alone Murray F. Brennan
16:45:00 patient and survivor care-- The Role of Surgical Management in Stage IV Melanoma (CPO18B) Howard Kaufman
16:45:00 clinical problems in oncology-- The Role of Surgical Management in Stage IV Melanoma (CPO18B) Howard Kaufman
16:45:00 sarcoma/bone and soft tissue cancers-- Benefit of Multimodality Management of Advanced Sarcoma: Why the Medical Oncologist Should Not Work Alone Murray F. Brennan
16:45:00 melanoma/skin cancers-- The Role of Surgical Management in Stage IV Melanoma (CPO18B) Howard Kaufman
16:45:00 clinical trials-- The End of P Values? Why Alternative Methods to Making Inferences May Be Superior Steven Hirschfeld
16:45:00 clinical problems in oncology-- Duration and Reinstitution of Chemotherapy for Stages III and IV Non-Small Cell Lung Cancer (CPO04A) Nasser H. Hanna
16:45:00 lung cancer-- Duration and Reinstitution of Chemotherapy for Stages III and IV Non-Small Cell Lung Cancer (CPO04A) Nasser H. Hanna
16:45:00 melanoma/skin cancers-- Melanoma in Children, Adolescents, and Young Adults David E Fisher
Tuesday, June 3, 2008
08:00:00 general oncology sessions-- Highlights of the Day III
08:00:00 clinical problems in oncology-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
08:00:00 tumor biology-- Tumor Biology and Human Genetics
08:00:00 patient and survivor care-- Cancer and Thrombosis III: The Role of Anticoagulation in the Treatment of Patients with Cancer Gary H. Lyman
08:00:00 sarcoma/bone and soft tissue cancers-- Sarcoma
08:00:00 patient and survivor care-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
08:00:00 special sessions-- Highlights of the Day III
08:00:00 patient and survivor care-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
08:00:00 lymphoma and plasma cell disorders-- Lymphoma and Plasma Cell Disorders
08:00:00 genitourinary cancer-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
08:00:00 health services research-- Cancer and Thrombosis III: The Role of Anticoagulation in the Treatment of Patients with Cancer Gary H. Lyman
08:00:00 gastrointestinal (noncolorectal) cancer-- Treating Localized Pancreatic Cancer: Are We Offering Patients the Best We Have? (CPO19B) Philip Agop Philip
08:00:00 central nervous system tumors-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
08:00:00 breast cancer-- Developmental Therapeutic Approaches to Triple-Negative Breast Cancer Edith A Perez
08:00:00 developmental therapeutics-- Developmental Therapeutic Approaches to Triple-Negative Breast Cancer Edith A Perez
08:00:00 gastrointestinal (noncolorectal) cancer-- Gastrointestinal (Noncolorectal) Cancer
08:00:00 breast cancer-- Breast Cancer—Metastatic
08:00:00 breast cancer-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
08:00:00 clinical problems in oncology-- Treating Localized Pancreatic Cancer: Are We Offering Patients the Best We Have? (CPO19B) Philip Agop Philip
09:00:00 developmental therapeutics-- Triple-Negative Breast: Metastatic Risk and Role of Platinum Agents
09:00:00 tumor biology-- Triple-Negative Breast: Metastatic Risk and Role of Platinum Agents
09:00:00 breast cancer-- Triple-Negative Breast: Metastatic Risk and Role of Platinum Agents
09:45:00 genitourinary cancer-- Treatment-Related Cardiovascular Disease in Survivors of Pediatric and Adult Cancers
09:45:00 lymphoma and plasma cell disorders-- Initial Therapy for Multiple Myeloma: Considerations for an Integrated Risk- Adapted Approach S. Vincent Rajkumar
09:45:00 head and neck cancer-- Radiotherapy, Surgery, Chemoradiotherapy, or Sequential Therapy for Head and Neck Cancer: Treatment Decision Making in a Heterogeneous and Complicated Patient Population (CPO12B) Jacques Bernier
09:45:00 developmental therapeutics-- DNA Repair Modulators Yves Pommier
09:45:00 lung cancer-- Proteomic Investigations in Lung Cancer
09:45:00 clinical problems in oncology-- Radiotherapy, Surgery, Chemoradiotherapy, or Sequential Therapy for Head and Neck Cancer: Treatment Decision Making in a Heterogeneous and Complicated Patient Population (CPO12B) Jacques Bernier
09:45:00 lung cancer-- Duration and Reinstitution of Chemotherapy for Stages III and IV Non-Small Cell Lung Cancer (CPO04B) Nasser H. Hanna
09:45:00 clinical problems in oncology-- Duration and Reinstitution of Chemotherapy for Stages III and IV Non-Small Cell Lung Cancer (CPO04B) Nasser H. Hanna
09:45:00 patient and survivor care-- Treatment-Related Cardiovascular Disease in Survivors of Pediatric and Adult Cancers
09:45:00 lymphoma and plasma cell disorders-- Treatment-Related Cardiovascular Disease in Survivors of Pediatric and Adult Cancers
11:30:00 sarcoma/bone and soft tissue cancers-- Complications of Cancer and Its Treatment: Identification, Evaluation, and Treatment of Neuromuscular and Musculoskeletal Sequelae and Lymphedema (CPO02B)
11:30:00 lung cancer-- Targeted and Novel Agents in Small Cell Lung Cancer Bruce E. Johnson
11:30:00 clinical problems in oncology-- Liver-Directed Therapy: Beyond Colon Metastasis (CPO06A) Michael A. Choti
11:30:00 clinical problems in oncology-- Complications of Cancer and Its Treatment: Identification, Evaluation, and Treatment of Neuromuscular and Musculoskeletal Sequelae and Lymphedema (CPO02B)
11:30:00 gastrointestinal (noncolorectal) cancer-- Liver-Directed Therapy: Beyond Colon Metastasis (CPO06A) Michael A. Choti
11:30:00 gastrointestinal (colorectal) cancer-- Liver-Directed Therapy: Beyond Colon Metastasis (CPO06A) Michael A. Choti
11:30:00 patient and survivor care-- Complications of Cancer and Its Treatment: Identification, Evaluation, and Treatment of Neuromuscular and Musculoskeletal Sequelae and Lymphedema (CPO02B)
11:30:00 lymphoma and plasma cell disorders-- Complications of Cancer and Its Treatment: Identification, Evaluation, and Treatment of Neuromuscular and Musculoskeletal Sequelae and Lymphedema (CPO02B)
13:15:00 ethics-- Early Data: Presenting and Publishing Preliminary Results Donna S. Neuberg
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.